Latest in Pulmonary News

Latest in Pulmonary News2019-02-15T07:28:32-05:00

Thirty-Day Hospital Readmission Metric Linked to Increased Mortality for HF and Pneumonia

Physicians are at increased pressure to reduce readmissions for certain chronic diseases. A recent study found that implementation of the 30-day readmission rules has been associated with increased 30-day post-discharge mortality for those hospitalized for heart failure and pneumonia.

Post-discharge deaths have increased by 0.25% for patients hospitalized with heart failure and by 0.40% for patients with pneumonia since the implementation of the 30-day readmission rules.
There are approximately 8 million hospitalizations during the study period. Such small increases may account for a large number of deaths.

The findings, published online in JAMA, come from a retrospective cohort study that compared mortality rates among 8.3 million Medicare beneficiaries hospitalized for these common conditions before and after implementation of the Hospital Readmissions Reduction Program (HRRP). This early data should lead physicians to exercise caution in discharging patients prematurely.

Source: Association of the Hospital Readmissions Reduction Program With Mortality Among Medicare Beneficiaries Hospitalized for Heart Failure, Acute Myocardial Infarction, and Pneumonia. JAMA. 2018;320(24):2542-2552. doi:10.1001/jama.2018.19232

Add Corticosteroids to Your Arsenal for the treatment of Inpatient Community-Acquired Pneumonia.

Corticosteroids were both beneficial and cost-effective for hospitalized adults with severe CAP. Hospitalized people with non-severe CAP may also benefit from corticosteroid therapy, but with no survival advantage

In 2015, results of two randomized trials showed that systemic corticosteroids were beneficial for some hospitalized patients with community-acquired pneumonia (CAP; NEJM JW Gen Med Mar 15 2015 and JAMA 2015; 313:677; NEJM JW Gen Med Mar 1 2015 and Lancet 2015; 385:1511). Now, two new meta-analyses — one by the Cochrane Library, and one by the Infectious Diseases Society of America (IDSA) — address whether CAP patients should receive systemic corticosteroids routinely.

These meta-analyses suggest that low-dose (≈40 mg), short-course (3–7 days) systemic corticosteroids should be strongly considered for hospitalized adults with severe CAP. These results do not apply to outpatients with CAP or to inpatients with hospital-acquired pneumonia or ventilator-associated pneumonia. Several ongoing randomized trials probably will clarify steroid use further for pneumonia indications.

Source:
The Cost-effectiveness of Corticosteroids for the treatment of Community-Acquired Pneumonia
Chest. 2018 Nov 15. pii: S0012-3692(18)32727-2. doi: 10.1016/j.chest.2018.11.001.
https://www.ncbi.nlm.nih.gov/pubmed/30448195?dopt=Abstract

Home oxygen therapy for COPD: Does it matter whether the patient is hypoxemic? Evidence vs Reality

Home oxygen therapy for COPD: Does it matter whether the patient is hypoxemic? Evidence vs Reality?

Long-term oxygen therapy (LTOT) is given to improve survival time in people with COPD and severe chronic hypoxemia at rest. The efficacy of oxygen therapy for breathlessness and health-related quality of life (HRQOL) in people with COPD and mild or no hypoxemia who do not meet the criteria for LTOT has not been established. Scientific evidence for its benefits of LTOT dates back to the 1980s when two randomized controlled trials showed prolonged survival in COPD-patients undergoing LTOT for at least 15 hours/day. In contrast, the potential benefits of LTOT in non-COPD-patients has not been well researched and the recommendations for its application are primarily extrapolated from trials on COPD-patients.

Recent Cochrane analysis found that oxygen can relieve breathlessness when given during exercise to mildly hypoxaemic and non-hypoxaemic people with chronic obstructive pulmonary disease who would not otherwise qualify for home oxygen therapy. Findings show that COPD patients without severe hypoxemia undergoing oxygen therapy during exercise training over time do not achieve better exercise capacity or health-related quality of life compared with placebo.

However, LTOT has a beneficial effect on quality of life, dyspnea, and exercise capacity in patients with COPD and exertional hypoxemia.

Source:
Oxygen for breathlessness in patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006429.pub3/full

J Bras Pneumol. 2018 Sep-Oct;44(5):390-397. doi: 10.1590/S1806-37562017000000019.
Impact of adherence to long-term oxygen therapy on patients with COPD and exertional hypoxemia followed for one year.
https://www.ncbi.nlm.nih.gov/pubmed/30517340

Latest in Pulmonary Research

  1. Cholon, DM, Aleksandrov, LA, Quinney, NL, Boyles, SE, Jensen, TJ, Aleksandrov, AA et al.. Implications for cystic fibrosis therapy: Potentiator icenticaftor is superior to ivacaftor in improving function and maintaining stability of F508del CFTR. Sci Prog. 2025;108 (4):368504251384892. doi: 10.1177/00368504251384892. PubMed PMID:41055920 .
  2. Baysal Bakır, D, Atay, Ö, Yağmur, H, Kabadayı, G, Tezcan, D, Asilsoy, S et al.. The Role of Nasal Cytology in the Phenotyping and Monitoring of Chronic Rhinitis in Children. Clin Otolaryngol. 2025; :. doi: 10.1111/coa.70040. PubMed PMID:41055895 .
  3. Zhou, SY, Zeng, YX, Tao, Y, Wang, JM. Association of MiR-29b/BRD4 with Airway Dysbiosis in Chronic Obstructive Pulmonary Disease after Smoking Cessation. Curr Med Sci. 2025; :. doi: 10.1007/s11596-025-00118-z. PubMed PMID:41055881 .
  4. Osterland, AJ, Wang, Y, Smith-Howell, ER, Wilson, TW, Patton, GA, Firozvi, KA et al.. Disparities in Stage at Diagnosis and Cancer Progression by Race and Socioeconomic Deprivation: A Pan-Tumor Analysis in the US Community Oncology Setting. J Racial Ethn Health Disparities. 2025; :. doi: 10.1007/s40615-025-02685-2. PubMed PMID:41055876 .
  5. Vizcarra-Melgar, J, Moreno-Luna, R, Martín-Jiménez, D, Gago-Torres, C, Palma-Martínez, C, González-García, M et al.. Phenotypic Features of Central Compartment Atopic Disease Compared with Other Types of Chronic Rhinosinusitis: A Systematic Review. Curr Allergy Asthma Rep. 2025;25 (1):43. doi: 10.1007/s11882-025-01225-6. PubMed PMID:41055835 .
  6. Elwyn, G, Gulbrandsen, P, Leavitt, H, Abukmail, E, Clayman, ML, Edwards, A et al.. Shared Decision-Making. A Primer for Clinicians. J Gen Intern Med. 2025; :. doi: 10.1007/s11606-025-09707-z. PubMed PMID:41055684 .
  7. Halm, EA, Del Vecchio, NJ, Rendle, KA, Tiro, JA, Zheng, Y, Winer, RL et al.. Longitudinal Adherence to Screening for Colorectal, Cervical, and Lung Cancer in a US Consortium. J Gen Intern Med. 2025; :. doi: 10.1007/s11606-025-09835-6. PubMed PMID:41055680 .
  8. Triana, AJ, Alford-Holloway, MN. The Role of Price Variation in Economic Analyses for Cancer Screenings: A Rapid Review. Appl Health Econ Health Policy. 2025; :. doi: 10.1007/s40258-025-01007-1. PubMed PMID:41055675 .
  9. Wang, D, Liu, T, Yin, B, Chang, Y, Hyon-U, P, Zhang, Y et al.. The lung pre-metastatic niche in osteosarcoma: Mechanism and therapeutic intervention. Int J Cancer. 2025; :. doi: 10.1002/ijc.70188. PubMed PMID:41055669 .
  10. Lin, C, Mao, M, Wu, Q, Qiu, X, Ma, D, Ding, C et al.. Bimetallic nanotubes enhanced MALDI-TOF MS for rapid detection of carbapenemase activity in Klebsiella pneumoniae. Anal Bioanal Chem. 2025; :. doi: 10.1007/s00216-025-06135-0. PubMed PMID:41055653 .
  11. Kanteres, T, Angelakopoulou, IM, Angelakopoulou, EA, Tsolaki, F, Tagarakis, G, Manika, K et al.. Lung microbiome dynamics in health and lung cancer. Microb Genom. 2025;11 (10):. doi: 10.1099/mgen.0.001509. PubMed PMID:41055637 .
  12. Wu, Q, Fan, Z, Su, H, Lei, T. Refining surgical decision-making for high-risk stage IA Non-Small cell lung cancer. J Thorac Cardiovasc Surg. 2025; :. doi: 10.1016/j.jtcvs.2025.09.009. PubMed PMID:41055635 .
  13. Amen, TB, Ibrahim, LI, Gillinov, SM, Torabian, KA, Dean, MC, Liimakka, A et al.. Glucagon-like peptide-1 Agonists and Common Hand Procedures: Perioperative and Postoperative Risks and Complications. J Hand Surg Am. 2025; :. doi: 10.1016/j.jhsa.2025.08.004. PubMed PMID:41055617 .
  14. Mingazova, EN, Kotlovskiy, MY, Muslimov, MI, Russkikh, SV. [DYNAMICS OF CHANGES IN THE INDICATOR OF THE INDEX OF PERSONNEL WELL-BEING IN THE HEALTHCARE SYSTEM OF THE REPUBLIC OF TATARSTAN]. Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2025;33 (0):2300. doi: 10.32687/0869-866X-2025-33-s1-. PubMed PMID:41055529 .
  15. Rozanov, VA, Semenova, NV, Vuks, AJ, Anokhina, MV, Isakov, VD, Neznanov, NG et al.. [SUICIDE MORTALITY IN THE REGIONS OF THE NORTH WESTERN FEDERAL DISTRICT IN THE POST PANDEMIC PERIOD]. Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2025;33 (0):902-911. doi: 10.32687/0869-866X-2025-33-s1-902-911. PubMed PMID:41055524 .
  16. Ahrar, K. How I Do It: CT-guided Percutaneous Transthoracic Lung Biopsy. Radiology. 2025;317 (1):e243593. doi: 10.1148/radiol.243593. PubMed PMID:41055500 .
  17. Liu, M, Li, M, Zheng, R, Wen, X, Zhang, X, Jiang, C et al.. Comparison of 10-year Survival Outcomes between CT Surveillance and Surgery for Ground-Glass Nodules. Radiology. 2025;317 (1):e250366. doi: 10.1148/radiol.250366. PubMed PMID:41055497 .
  18. Ryazantsev, SV, Ryazantsev, NS, Khramova, MN. [ON THE ISSUE OF REMITTANCES BY EXPATRIATES FROM CENTRAL ASIA TO RUSSIA DURING COVID-19 PANDEMIC UNDER THE PRISM OF MIGRATION NEOCLASSICAL THEORY]. Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2025;33 (4):680-686. doi: 10.32687/0869-866X-2025-33-4-680-686. PubMed PMID:41055470 .
  19. Khabriev, RU, Mingazova, EN. [THE LONG-TERM TRENDS OF MAIN MEDICAL DEMOGRAPHIC INDICATORS OF THE REPUBLIC OF TATARSTAN: THE METHODICAL APPROACH TO STUDYING PROCESSES AT THE LEVEL OF THE REGIONS]. Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2025;33 (4):545-556. doi: 10.32687/0869-866X-2025-33-4-545-556. PubMed PMID:41055463 .
  20. Tchorz, JP, Ladar, P, Lessani, M, Fitzek, S. Incidence of Cracked Teeth Before, During, and After the Covid-19 Pandemic-A Retrospective Analysis in a German Private General Practice. Clin Exp Dent Res. 2025;11 (5):e70239. doi: 10.1002/cre2.70239. PubMed PMID:41055458 .
  21. Džida, S, Jerković Raguž, M, Kraljević, D, Nikše, T, Mabić, M, Pavlović, K et al.. Prevalence of asthma, allergic rhinitis, and atopic dermatitis and their association with risk factors in children in the southern region of Bosnia and Herzegovina (BiH). J Asthma. 2025; :1-13. doi: 10.1080/02770903.2025.2570701. PubMed PMID:41055385 .
  22. Grandbastien, B, Mauffrey, F, Greub, G, Blanc, DS. Legionella detection and enumeration in water samples by ISO 11731-2017: which method is the most sensitive?. Appl Environ Microbiol. 2025; :e0114725. doi: 10.1128/aem.01147-25. PubMed PMID:41055376 .
  23. Vashi, AA, Bozkurt, S, Urech, T, Wu, S, Asch, SM, Tran, LD et al.. Persistent Emergency Department Use Among Veterans: Longitudinal Patterns and Opportunities for Targeted Intervention. Mil Med. 2025; :. doi: 10.1093/milmed/usaf479. PubMed PMID:41055346 .
  24. Sekhon, H, Kageyama, R, Sprenkle, NT, Happ, HC, Wigton, EJ, Pua, HH et al.. DeepRNA-Reg: a deep-learning based approach for comparative analysis of CLIP experiments. RNA Biol. 2025;22 (1):1-18. doi: 10.1080/15476286.2025.2564941. PubMed PMID:41055236 .
  25. Naicker, K, Ranchod, D, Msiza, K, Mosebetsane, I, Thulo, M, Mabunda, N et al.. COVID-19 impact on blood donation and blood product use in Mangaung Metropolitan Municipality. S Afr Fam Pract (2004). 2025;67 (1):e1-e9. doi: 10.4102/safp.v67i1.6177. PubMed PMID:41055163 .
Search PubMed

Search Terms: Asthma, COPD, Lung Cancer, Pneumonia, Pulmonary Fibrosis

Copyright © 2016 Allergy Sleep & Lung Care. All Rights Reserved.
This website does not contain medical advice and the use of this website does not create a physician/patient relationship between you and Allergy Sleep & Lung Care.
Terms of Use | HIPAA Privacy Policy | Sitemap | Privacy Policy

Go to Top